Amneal Pharmaceuticals (AMRX) EBIT (2017 - 2026)
Amneal Pharmaceuticals' EBIT came in at $95.42 million for Q3 2026, up 35.6% from $70.34 million a year earlier but down 26.5% from the prior quarter.
Amneal Pharmaceuticals (AMRX) EBIT (2017 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Amneal Pharmaceuticals reported EBIT of $478.99 million, up 33.8% year-over-year; for FY2025, it was $394.1 million, up 58.1% from FY2024.
- EBIT carries a five-year compound annual growth rate of 34.0% (FY2020 to FY2025).
- Going back by year, EBIT was $249.33 million in FY2024 (+22.0%), $204.37 million in FY2023, -$94.93 million in FY2022 and $152.72 million in FY2021 (+67.5%).
- The five-year range for quarterly EBIT is -$198.62 million (Q2 2022) to $141.77 million (Q1 2026).
- Year-over-year, EBIT has increased for four consecutive quarters, with growth averaging 81.6% over the last seven quarters.
- The fastest year-over-year change in EBIT over five years came in Q4 2024 (growth of 434.0%), and the weakest in Q4 2023 (a decline of 60.6%).
- Business Quant data shows AMRX's EBIT at $129.77 million (Q2 2026), $141.77 million (Q1 2026) and $112.03 million (Q4 2025) in the three quarters before Q3 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | 8.41 Bn |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | 6.18 Bn |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | 6.27 Bn |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | 5.56 Bn |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | 4.39 Bn |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | 3.71 Bn |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | 3.46 Bn |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | 5.47 Bn |
| 10 | Amneal Pharmaceuticals | 7.10 Bn | 6.33 Bn | 334.12 Mn | 95.42 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 95.42 Mn |
| Jun 30, 2026 | 129.77 Mn |
| Mar 31, 2026 | 141.77 Mn |
| Dec 31, 2025 | 112.03 Mn |
| Sep 30, 2025 | 70.34 Mn |
| Jun 30, 2025 | 111.37 Mn |
| Mar 31, 2025 | 100.35 Mn |
| Dec 31, 2024 | 75.79 Mn |
| Sep 30, 2024 | 88.81 Mn |
| Jun 30, 2024 | 95.47 Mn |
| Mar 31, 2024 | -10.75 Mn |
| Dec 31, 2023 | 14.19 Mn |
| Sep 30, 2023 | 75.65 Mn |
| Jun 30, 2023 | 80.08 Mn |
| Mar 31, 2023 | 34.45 Mn |
| Dec 31, 2022 | 36.03 Mn |
| Sep 30, 2022 | 44.35 Mn |
| Jun 30, 2022 | -198.62 Mn |
| Mar 31, 2022 | 23.31 Mn |
| Dec 31, 2021 | 11.18 Mn |
Amneal Pharmaceuticals EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=AMRX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "AMRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=AMRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();